StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical r&d expenses

Research and development expenses are spending on new products and technology.

Rockwell Medical's R&D Expenses for the twelve months ending Dec 31, 2025 was $0, down 100.0% year over year. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $48.27M in fiscal 2012.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$19.00K-98.3%
FY2023Dec 31, 2023$1.11M-64.5%
FY2022Dec 31, 2022$3.12M-54.4%
FY2021Dec 31, 2021$6.84M-3.6%
FY2020Dec 31, 2020$7.09M+3.0%
FY2019Dec 31, 2019$6.89M+22.0%
FY2018Dec 31, 2018$5.64M-10.7%
FY2017Dec 31, 2017$6.32M+8.2%
FY2016Dec 31, 2016$5.84M+17.7%
FY2015Dec 31, 2015$4.96M-36.3%
FY2014Dec 31, 2014$7.78M-80.2%
FY2013Dec 31, 2013$39.38M-18.4%
FY2012Dec 31, 2012$48.27M+171.1%
FY2011Dec 31, 2011$17.81M+420.3%
FY2010Dec 31, 2010$3.42M-47.0%
FY2009Dec 31, 2009$6.45M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$40.00K–
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$1.00K-99.4%
Q3 FY2024Sep 30, 2024$0-100.0%
Q2 FY2024Jun 30, 2024$0-100.0%
Q1 FY2024Mar 31, 2024$18.00K-93.5%
Q4 FY2023Dec 31, 2023$168.00K+7.7%
Q3 FY2023Sep 30, 2023$494.00K+5.3%
Q2 FY2023Jun 30, 2023$167.00K-82.0%
Q1 FY2023Mar 31, 2023$278.00K-82.3%
Q4 FY2022Dec 31, 2022$156.00K-88.8%
Q3 FY2022Sep 30, 2022$469.00K-61.6%
Q2 FY2022Jun 30, 2022$926.00K-61.7%
Q1 FY2022Mar 31, 2022$1.57M-13.4%
Q4 FY2021Dec 31, 2021$1.39M-27.2%
Q3 FY2021Sep 30, 2021$1.22M-30.0%
Q2 FY2021Jun 30, 2021$2.42M+49.5%
Q1 FY2021Mar 31, 2021$1.81M-0.7%
Q4 FY2020Dec 31, 2020$1.91M-2.4%
Q3 FY2020Sep 30, 2020$1.75M+18.3%
Q2 FY2020Jun 30, 2020$1.62M-45.4%
Q1 FY2020Mar 31, 2020$1.82M+266.4%
Q4 FY2019Dec 31, 2019$1.96M+21.6%
Q3 FY2019Sep 30, 2019$1.48M+82.5%
Q2 FY2019Jun 30, 2019$2.96M+89.8%
Q1 FY2019Mar 31, 2019$497.28K-70.2%
Q4 FY2018Dec 31, 2018$1.61M-24.3%
Q3 FY2018Sep 30, 2018$808.19K-38.1%
Q2 FY2018Jun 30, 2018$1.56M-7.0%
Q1 FY2018Mar 31, 2018$1.67M+37.2%
Q4 FY2017Dec 31, 2017$2.13M+77.1%
Q3 FY2017Sep 30, 2017$1.30M+3.4%
Q2 FY2017Jun 30, 2017$1.68M–
Q1 FY2017Mar 31, 2017$1.21M–
Q4 FY2016Dec 31, 2016$1.20M–
Q3 FY2016Sep 30, 2016$1.26M–

More Rockwell Medical figures

See a number that looks wrong?